Engimmune Therapeutics
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Engimmune Therapeutics Information
Geographic Data
Address: -
City: Basel
State: basel-city
Zip: -
Country: CH
Financial Info
Stage:
seed
Raised Last:
$16M
Raised Total:$16M
Social
Metrics
5,427,469Website Global Rank
1,558Website Monthly Traffic
Twitter Followers
Description
Engimmune Therapeutics is a platform and product development company using cutting-edge technologies in the life sciences engineering highly potent and specific therapies based on T cell receptors (TCR) targeting solid tumors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2022 | Seed Round | 2 | $15.8M |
Novo Holdings Pureos Bioventures Novo Holdings Pureos Bioventures |
2/2022 | Pre Seed Round | $0 |
BaseLaunch BaseLaunch |
5/2022 | Seed | $16.7M |
Pureos Bioventures Novo Holdings |
2/2022 | Pre Seed Round | 1 | $545.9k |
BaseLaunch BaseLaunch |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
